avatar

Xiidra Prior to Shire: How SARcode Took on the Odds to Pursue a New Treatment for Dry Eye

OIS Podcast | Ophthalmology's leading Podcast
OIS Podcast | Ophthalmology's leading Podcast
Episode • Sep 8, 2016 • 33m
Shire scored a huge win this summer by securing FDA approval of Xiidra. Hear from three principals of SARcode Bioscience, the start-up that discovered the Dry Eye treatment – then known as lifitegrast.

Switch to the Fountain App